Facilitators and barriers to maternal immunization and strategies to improve uptake in low-income and lower-middle income countries: A systematic review
Tila Khan Simran Malik Liya Rafeekh Sayantan Halder Sapna Desai Sangeeta Das Bhattacharya a School of Medical Science & Technology,Indian Institute of Technology,Kharagpur,Indiab Population Council Institute,New Delhi,IndiaTila Khan is a DBT/Wellcome Trust India Alliance Fellow in School of Medical Science & Technology at Indian Institute of Technology – Kharagpur,Kharagpur,West Bengal,India. She is a member of the Indian Public Health Association,Lancet Citizens' Commission on Reimagining India's Health System and International Society for Infectious Diseases. Dr Khan obtained her undergraduate degree in veterinary medicine in 2005 and MVSc. in biotechnology in 2007 from Govind Ballabh Pant University of Agriculture & Technology before studying at the Virginia Tech,University,USA,obtaining her Ph.D. in 2012 in Molecular Virology. Her post PhD positions have largely been in School of Medical Science & Technology. Her research interests are molecular epidemiology,respiratory infections,virology,vaccinology,vaccine access,vaccine policy and evidence-based research. She received the Robert Austrian Research Award in pneumococcal vaccinology at Scotland in June 2016. She is a recipient of the prestigious DBT/Wellcome Trust India Alliance Early Career Fellowship 2020 in Clinical and Public Health Research on building the evidence base for maternal influenza and RSV immunization to protect infants from lower respiratory tract infections. In June 2023,she was a visiting scholar in the International Vaccine Access Center at the John Hopkins Bloomberg School of Public Health in Baltimore.
DOI: https://doi.org/10.1080/21645515.2024.2411823
2024-10-31
Human Vaccines & Immunotherapeutics
Abstract:Maternal immunization (MI) is an emerging strategy to combat infant mortality in low-income (LIC) and lower-middle income countries (LMIC). We conducted a systematic review to identify the facilitators and barriers to MI and strategies that improve uptake in LICs and LMICs. We searched PubMed, Cochrane Library, and Scopus for quantitative, qualitative, and mixed-methods studies published in English from January 1, 2011, to October 31, 2021, from all LICs and LMICs. Data was appraised using the Mixed Methods Appraisal Tool. 55 studies were included. The major barriers were low knowledge and concern of vaccine safety among pregnant women and healthcare providers (HCP). HCP's recommendation, maternal knowledge, vaccine confidence and ≥4 antenatal care (ANC) visits facilitated uptake. The key strategies encompassed health financing, reminders, intersectoral coordination, integration, community engagement, capacity building, and education. Community-based delivery models were effective. Tailored programs are needed to improve ANC access, and educate pregnant women and HCPs.
immunology,biotechnology & applied microbiology